ALS and MS Clinical Data from Clene's CNM-Au8® Featured in Multiple Presentations at the 2023 American Academy of Neurology Annual Meeting

SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) a...

Related Keywords

Harvard University ,Massachusetts ,United States ,Utah ,Maryland ,Salt Lake City ,Boston ,Sydney ,New South Wales ,Australia ,American ,David Schull ,Kevin Gardner ,Michael Barnett ,James Berry ,Rob Etherington ,Ignacio Guerrero Ros ,Nasdaq ,University Of Sydney ,Access Program ,American Academy Of Neurology ,Twitter ,Exchange Commission ,Clene Inc ,Linkedin ,Russo Partners ,Clene Nanomedicine Inc ,Facebook ,Clene Nanomedicine ,Annual Meeting ,Massachusetts General Hospital ,Survival Benefit ,Across Three Study Populations ,Expanded Access ,Private Securities Litigation Reform Act ,Annual Report ,新浪香港 ,新浪 ,新浪網 ,香港 ,Sina ,Sina Com Hk ,Hong Kong ,